18/03/2022

The SARS-CoV-2 virus appeared in China at the end of 2019, in the city of Wuhan. It belongs to the family of Coronaviridae and subgenus Sarbecovirus. Since then, other genetic variants of concern (VOCs) have emerged. These variants carry mutations that are associated with increased transmissibility (L452R) or possible immune escape (L452R, E484K and E484Q)

In terms of clinical presentation, the symptoms range in their severity from mild to severe.

The diagnosis of SARS-CoV-2 infection today is based primarily on the presence of detection of viral RNAby real-time RT-PCR. Standard run times for RT-PCR reactions are 90 minutes, with variant detection performed as a reflex test, or via sequencing. The EBX-047 assay detects original Sars-cov-2 and key variants in the same run, reducing turnaround time.